In contrast to young growing animals, pressure-overload hypertrophy in adults is frequently associated with diminished myocardial capillary density and maximal coronary flow per gram. To determine the role of angiogenesis in maintaining perfusion capacity in the hypertrophying heart, the angiogenesis inhibitor protamine sulfate was administered to young lambs during the development of left ventricular (LV) pressure-overload hypertrophy. Baseline and maximum (adenosine) myocardial perfusion was measured in four groups of chronically instrumented 10-week-old lambs subjected to 1) ascending aortic bands since the age of 4 weeks (LVH group, n=10), 2) sham operation at the age of 4 weeks (SHAM group, n=8), 3) aortic bands and twice daily injections of protamine since the age of 4 weeks (LVHI+P group, n=9), 4) sham operation and injection of protamine (SHAM+P group, n =8). Capillary density was measured postmortem. Peak LV pressure and the LV/body weight ratio were similarly increased in LVH and LVH+P compared with sham-operated lambs (p<0.001). In LVH lambs, LV capillary number increased by 32% compared with sham-operated lambs (p<0.05), and capillary density, coronary flow reserve, and minimal coronary resistance remained normal. In contrast, LVH+P lambs had no significant increase over SHAM lambs in LV capillaries and total maximum coronary flow. The LVH+P lambs had lower LV subendomyocardial capillary density and higher minimal coronary resistance per gram (p<0.05 versus LVH lambs). Right ventricular capillary density and minimal resistance were similar in all groups. These findings support the hypotheses that myocardial angiogenesis with pressure-overload hypertrophy is important in maintaining maximal LV coronary flow in the young and that impairment of angiogenesis results in diminished coronary flow capacity. (Circulation Research 1991;68:1458-1470 
In contrast to young growing animals, pressure-overload hypertrophy in adults is frequently associated with diminished myocardial capillary density and maximal coronary flow per gram. To determine the role of angiogenesis in maintaining perfusion capacity in the hypertrophying heart, the angiogenesis inhibitor protamine sulfate was administered to young lambs during the development of left ventricular (LV) pressure-overload hypertrophy. Baseline and maximum (adenosine) myocardial perfusion was measured in four groups of chronically instrumented 10-week-old lambs subjected to 1) ascending aortic bands since the age of 4 weeks (LVH group, n=10), 2) sham operation at the age of 4 weeks (SHAM group, n=8), 3) aortic bands and twice daily injections of protamine since the age of 4 weeks (LVHI+P group, n=9), 4) sham operation and injection of protamine (SHAM+P group, n =8). Capillary density was measured postmortem. Peak LV pressure and the LV/body weight ratio were similarly increased in LVH and LVH+P compared with sham-operated lambs (p<0.001). In LVH lambs, LV capillary number increased by 32% compared with sham-operated lambs (p<0.05), and capillary density, coronary flow reserve, and minimal coronary resistance remained normal. In contrast, LVH+P lambs had no significant increase over SHAM lambs in LV capillaries and total maximum coronary flow. The LVH+P lambs had lower LV subendomyocardial capillary density and higher minimal coronary resistance per gram (p<0.05 versus LVH lambs). Right ventricular capillary density and minimal resistance were similar in all groups. These findings support the hypotheses that myocardial angiogenesis with pressure-overload hypertrophy is important in maintaining maximal LV coronary flow in the young and that impairment of angiogenesis results in diminished coronary flow capacity. (Circulation Research 1991;68:1458-1470) P ressure-overload hypertrophy of the left ven- tricle (LV) is associated with dysrhythmias,' pump dysfunction,2'3 and death.' How hypertrophy is linked to these abnormalities is unknown, although inadequate coronary perfusion may play an etiologic role.2'4 Clinical4 and experimental studies in animals2-'2 have demonstrated abnormal coronary perfusion in adults with pressure-overload hypertro-during the time course of the hypertrophy. 4 Due to limitations in manipulating these factors independently, it is unclear which are actually important in mediating the observed diminution in coronary reserve with hypertrophy. 4-6"12 This investigation focuses on the role of microvascular growth in maintaining coronary vascular flow capacity in the hypertrophied LV. In adult animals with pressure-overload hypertrophy, there is increased myocyte diameter and ventricular thickness without significant microvascular hyperplasia13'15'21 '22 (for review see Reference 16) , which results in increased intercapillary diffusion distance16,23 and diminished arteriolar density.11 '24 In contrast, in young growing animals there is concurrent physiological growth of the myocardium and coronary microvasculature.12"14'15 '25 With pressure-overload hypertrophy in the immature animal, there is increased cardiac myocyte and nonmuscle cell proliferation,22 normal capillary density,1213"15'16 and normal coronary vascular flow reserve. 10, 12, [26] [27] [28] [29] [30] Hence, investigation of the coronary circulation of the immature hypertrophying heart could provide information concerning the mechanisms influencing myocardial perfusion with pressure overload.
Recently, a number of factors that modulate angiogenesis have been found in myocardium, including acidic fibroblast growth factor (aFGF), basic fibroblast growth factor (bFGF), and heparinlike polysaccharides. [31] [32] [33] [34] [35] Agents that inhibit angiogenesis have also been described. 36 Protamine sulfate reversibly inhibits endothelial binding of bFGF37 as well as endothelial cell mitogenesis32'37 and migration38 induced by bFGF in vitro. When administered systemically, protamine also reversibly inhibits angiogenesis in vivo in a number of different systems,36 '39 including capillary growth in the coronary vasculature. 40 Rakusan and Turek40 demonstrated that myocardial capillary growth during early postnatal development is impeded by protamine. In the current investigation, protamine was used to determine whether coronary angiogenesis could be inhibited in young growing lambs with pressure overload and to study the role of coronary microvascular growth in maintaining perfusion in the hypertrophying heart. By altering microvascular growth independent of other factors that may contribute to diminished coronary perfusion, we hoped to corroborate the hypothesis that a limitation in coronary vascular growth leads to diminished coronary perfusion capacity. We show that in the hypertrophying young heart, protamine treatment both diminishes capillary density and maximal coronary perfusion. Because the effect of protamine on coronary flow reserve does not appear secondary to altered coronary vascular reactivity, it suggests that limited coronary vascular growth with hypertrophy is an important factor that could lead to diminished perfusion reserve with hypertrophy. Four groups of lambs received a thoracotomy at 4 weeks of age and were subsequently studied 6 weeks later. The thoracotomy was performed in the third right intercostal space using sterile surgical technique and general anesthesia with halothane and intravenous ketamine (10 mg/kg/hr, Quad Pharmaceuticals, Inc., Indianapolis, Ind.). Arterial pressure was monitored using a pigtail catheter (UMI Corp., Ballston Spa, N.Y.) or vascular sheath (Cordis Corp., Miami, Fla.) placed percutaneously in the femoral artery.
The SHAM group (n=8) underwent dissection of the aortic root and encirclement of the aorta with umbilical tape, which was then removed. In all experimental groups, the thorax was closed in layers and evacuated with a chest tube. All catheters and tubes were removed after surgery. The lambs were monitored and given 2 ml i.m. penicillin-streptomycin (Combiotic, Pfizer Inc., New York), twice daily for 5 days.
The LVH group (n=10) received an ascending aortic band to induce LV pressure overload. Simultaneous arterial and LV pressures were monitored using the side arm of a 6F sheath in the femoral artery and a 5F pigtail catheter advanced through the sheath into the LV. Umbilical tape was encircled twice around the ascending aorta and tightened until LV systolic pressure was 25-35 mm Hg greater than peak femoral pressure. The systolic pressure gradient increased as the lambs grew (see "Results").
The SHAM+P group (n=8) underwent a surgical procedure similar to that of the SHAM group. In addition, they received 10 mg/kg body wt s.c. protamine sulfate (Sigma Chemical Co., St. Louis) twice daily for 6 weeks starting the day of the procedure at 4 weeks of age. Protamine was administered in a 50 mg/ml solution of normal saline buffered with HEPES (Sigma). The dose per body surface area was similar to that previously reported to inhibit murine angiogenesis in growing myocardium40 and tumors. 36, 39 Preliminary studies showed that larger doses caused inhibition of growth or weight loss. To examine the influence of protamine in sheep without coexisting physiological coronary growth, 2-year-old adult sheep (n=4) underwent thoracotomy and the same protocol of protamine administration. The data from the protamine-treated adult sheep were compared with untreated adult sham-operated controls (n=6) and analyzed separately from SHAM+P lambs.
The LVH+P group (n=9) underwent the same banding procedure as did the LVH lambs and received protamine sulfate chronically for 6 weeks, as described for the SHAM+P group. Two additional lambs in the LVH+P group and two in the LVH group died suddenly with no apparent cause found at autopsy and were excluded from further analysis. None of the SHAM or SHAM+P lambs died before instrumentation.
To determine baseline capillary morphometrics at entry into the study, an additional BASE group (n=9) of lambs did not undergo thoracotomy but were killed at 4 weeks of age for histological studies (see below).
Instrumentation
At On the day of study, the lambs were weighed and sedated with 10 mg/kg i.m. ketamine, and a 7F sheath (Cordis) was placed percutaneously in the right femoral artery. A transducer-tipped catheter (model SPC-350, Millar Instruments, Houston) was advanced through the sheath into the thoracic aorta. The aortic and left atrial fluid-filled catheters were connected to strain-gauge pressure transducers (model P231D, Gould Inc., Oxnard, Calif.). The strain-gauge pressure transducers and the transducer-tipped catheter were calibrated in vitro with a mercury manometer before each study. The zero offset of the transducer-tipped catheter was crosscalibrated in vivo using the aortic fluid-filled catheter. The transducer-tipped catheter was then advanced into the LV using fluoroscopy.
Data Collection
At least 60 minutes after catheter placement, LV and aortic pressure were amplified, displayed through a multichannel recorder (Gould model 2800 V or model E/M AR 6V, Honeywell Inc., Pleasantville, N.Y.), and recorded on an eight-channel analog tape recorder (model 8868A, Hewlett-Packard Co., Palo Alto, Calif.). Cardiac output and regional myocardial blood flow were measured with radiolabeled (46Sc, 85Sr, 141Ce, or 1251) 15±2-gtm microspheres suspended in 10% dextran (3M, St. Paul, Minn.).6 The microspheres were dispersed by vortex agitation, ultrasonically separated for at least 60 minutes, and again vigorously agitated for 1 minute immediately before use. A reference arterial sample was collected over 120 seconds from the aortic catheter into a preweighed heparinized syringe using a withdrawal pump (model 600-910/920, Harvard Apparatus, South Natick, Mass.) at 7 ml/min, starting 30 seconds before injection of 1-5 x 106 microspheres into the left atrium. The reference sample flow rate was calculated as the weight of the blood collected per minute divided by the specific gravity. Data were rejected and measurements were repeated if LV pressure and heart rate varied by more than 20% during administration of microspheres. Blood pressure and flow were measured at baseline and during intravenous infusion of adenosine (Sigma) at 4 ,uM/ kg/min for a duration of 20-25 minutes. The dose8 and duration43 of adenosine administered has previously been demonstrated to result in maximal myocardial blood flow and minimal coronary vascular resistance. In preliminary studies in sheep, increasing doses of adenosine from 2 to 8 ,uM/kg/min resulted in no greater decrease in coronary vascular resistance. In this study, myocardial blood flow measured during infusion of adenosine is termed "maximum" and coronary resistance with adenosine is termed "minimum." Coronary flow reserve is the increase in flow from baseline to maximum flow. 44 At the end of each experiment, the lambs were sedated with ketamine, and the heart was arrested in diastole with potassium chloride. The heart was immediately excised, drained, trimmed of epicardial fat, and weighed. Growth of the ventricles from the age of 4 weeks (at aortic banding or sham surgery) to study at age 10 weeks was estimated by comparison with the mean LV and right ventricular (RV) weight of the 4-week-old BASE lambs. The heart was divided into eight regions (LV apex, LV anterior papillary muscle, LV posterior free wall, LV posterior papillary muscle, LV anterior free wall, mid septum, RV papillary muscle, and RV free wall). Samples were excised for histology. The remainder of each region was divided into three transmural layers, 0.4-2.0 g in weight, of approximately equal thickness for assessment of blood flow. The radioactivity in isotope standards, reference arterial blood samples, and myocardial tissue samples were counted in duplicate for 10 minutes in a gamma well counter (LKB 1282 Compugamma, LKB Diagnostics, Inc., Gaithersburg, Md.) at appropriate energy windows and corrected for background and crossover activity using an on-line computer program (ULTRA TERM, LKB Diagnostics). Regional layer flows were calculated using the formula Qt=Qr.(Ct/Cr), where Qt is tissue sample flow rate, Qr is reference sample flow rate (in milliliters per minute), Ct is tissue sample count rate, and Cr is reference sample count rate; the result was then divided by the sample weight and expressed as flow in milliliters per minute per gram tissue.6 Transmural regional flow was calculated as the sum of flow in the three transmural layers divided by the weight of the tissues from the three layers and expressed in milliliters per minute per gram. LV blood flow per gram was calculated as the sum of flow in all six LV regions divided by the combined tissue weight. Total LV coronary flow was calculated as LV flow per gram times LV weight (in grams). Total RV coronary flow was calculated in a similar manner from the two regions analyzed. Cardiac output was calculated as Qrx Cs/Cr, where Cs is count rate per milliliter aliquot from microsphere vial, and indexed to body weight by dividing by body weight in kilograms.
The analog tape recording was converted into a digital format by transfer to a microcomputer-based workstation with an eight-channel analog-to-digital conversion system sampling at a rate of 250 samples/ channel/sec. A composite average beat was calculated from 17.5 seconds of data. The averaged waveform was used to calculate mean and diastolic coronary perfusion pressure. Since ascending aortic pressure proximal to the aortic band was difficult to measure repeatedly, the coronary mean pressure was calculated, using the method described by Bache et al,8 as the integrated LV pressure from the onset of the aortic pressure upstroke to the dicrotic notch plus the integrated distal aortic diastolic pressure from the dicrotic notch to the onset of systolic upstroke, divided by the cycle length. The calculated mean coronary pressure and diastolic pressures were accepted as valid since they were always similar to directly measured pressures in the ascending aorta when obtained. Diastolic perfusion pressure was calculated as the mean difference between the aortic and ventricular pressures during the time period from the aortic dicrotic notch to the systolic upstroke. Coronary vascular resistance for each region of myocardium was calculated as the ratio of coronary mean pressure and the measured transmural flow to all layers of that myocardial region. The hemodynamic severity of the aortic stenosis was assessed by using the cardiac output and the gradient between the LV and aortic peak systolic pressure.
Histological Evaluation
Capillary density in the myocardium was assessed at the age of entry into the study, at 4 weeks of age in BASE lambs and at 10 weeks of age in the other lamb groups. Longitudinal and transverse sections of LV anterior papillary, posterior LV free wall, and RV free wall myocardium were excised, and the epicardium was marked with india ink. Specimens were frozen in liquid N2 within 1 hour postmortem and later stored at -70°C. Ten-micrometer sections were cut in a cryostat, fixed in acetone (4°C for 5 minutes), and stained by the indoxyl tetrazolium method for alkaline phosphatase, an enzyme specific for the endothelium. Sections were stained, as previously described,45 with 5-bromo-4-chloro-3-indolyl phosphate, toluidine salt, and nitro blue tetrazolium (Sigma) in a buffer of MgSO4 and sodium metaborate (pH 9.2-9.4) for 16 hours. No counterstain was used.
Coronary cross-sectional capillary density was analyzed in the inner one third of the LV papillary muscle (CDLV endo) in the middle third of the LV free wall myocardium (CDLV mid), and in the midwall of the RV. Capillary density was assessed by counting the mean number of capillaries within a 141 x 141-,gm graticule grid in 10-20 randomly chosen cross-sectional fields at x 320 magnification (model ICM, Zeiss, FRG). Since many hearts had a capillary "blush" in the immediate subendomyocardial region, the area within 50 ,tm of the endocardial surface was excluded from analysis. In each myocardial region, 400-800 capillaries were counted. The observer was unaware of the group identity of the slide during histological analysis of the capillaries. Posterior LV wall thickness (W) was measured at x10 from a transverse cross-sectional slide of the LV taken between the heads of the anterior and posterior papillary muscles. The number of capillaries (N) in a transverse linear array across the ventricular wall was calculated from the cross-sectional capillary density by assuming a distribution in a close hexagonal array25 using the formula
Results are reported as mean±+SEM. Statistical analysis of the differences between the four primary experimental groups was performed using a multifactorial analysis of variance with a 2 x 2 design examining the effects of hypertrophy and protamine. Differences in parameters compared simultaneously with additional groups were analyzed using a one-way analysis of variance. When the computed F value indicated p< 0.05, intergroup mean values were compared by using the Student-Newman-Keuls test. Student's t test was used for comparison of paired data within lamb groups and between adult sheep groups.
Linear and nonlinear regression analysis was used to examine the relation of coronary vascular resistance to capillary density. Since the exact relation between coronary vascular resistance and vascular growth is unknown,18 several possible relations were explored. Nonlinear experimental fits were calculated using a power function of the form Y=aXb+c and a nonlinear least-squares method. Third-order polynomial curve fits (Y=aX'+bX2+cX+d) were calculated using direct least-squares methods. For the two hypertrophy groups and for the pooled data, the nonlinear models did not provide a significant reduction in unexplained variance over simple linear regression, and the results of the latter are therefore presented.
Results

Somatic and Myocardial Growth
Body weight and heart weight data are shown in Table 1 . Body weight increased 28% in lambs with and in lambs without aortic bands, from 4 weeks of age at the time of the initial thoracotomy to 10 weeks of age at the time of the study. Lambs receiving protamine had an 18% growth in body weight, which 
Hemodynamic Data
Systemic hemodynamics are shown in Table 2 . Six weeks after aortic banding, baseline peak LV pressure in the LVH and LVH+P groups was elevated to 168±+10 and 168±+5 mm Hg, respectively (p<0.001 compared with SHAM and SHAM+P groups). The severity of aortic stenosis was hemodynamically similar in LVH and LVH+P groups, since the systolic peak-to-peak pressure gradient between the LV and aorta was similar (74±12 and 79±12 mm Hg, respectively) and the cardiac index and heart rate were similar in all groups. End-diastolic LV pressures were slightly but not significantly higher in lambs with aortic bands. Calculated coronary mean pressure and diastolic perfusion pressure were similar in LVH and LVH+P groups.
Adenosine infusion decreased systemic vascular resistance and aortic pressures and increased cardiac index similarly in all four groups (Table 2) . LV peak pressure, systolic peak-to-peak pressure gradient, coronary mean pressure, and diastolic perfusion pressure were the same in LVH and LVH+P during adenosine infusion. Although the relative change in systemic vascular resistance in response to adenosine was similar in all groups, the absolute level was higher in SHAM+P lambs (p=0.034 nontreated versus protamine-treated).
Myocardial Perfusion
Total LV blood flow (in milliliters per minute) in sham-operated lambs was unaffected by protamine at baseline and increased similarly in response to adenosine-induced vasodilation by 313% and 311% in SHAM and SHAM+P lambs, respectively ( Figure  1A ). In the LVH and LVH+P lambs, baseline total LV blood flow was similarly greater than in the groups without hypertrophy (p<0.05). Although baseline LV coronary flow in LVH lambs was elevated, it still increased threefold with adenosine, similar to the SHAM and SHAM+P lambs. Thus, LV hypertrophy in young lambs did not impair coronary flow reserve. In contrast, while the LVH+P lambs had a LV baseline blood flow 69% greater than that of sham-operated lambs (p<0.01), maximal total LV blood flow was only 24% more than that of shamoperated lambs and was less than that in LVH lambs (p=0.06).
Myocardial oxygenation during periods of stress and increased myocardial oxygen consumption is dependent on the degree to which coronary blood flow per gram of myocardium can increase.44 Maximal and baseline myocardial perfusion expressed as coronary flow per gram LV are demonstrated in Figure 1B . The elevated LV blood flow in lambs with hypertrophy was not entirely due to the higher LV weight since baseline LV perfusion per gram was 54% higher than that of SHAM and SHAM+P lambs (p<O.Ol). Since coronary flow reserve was similar in LVH and unbanded lambs, maximal transmural LV perfusion per gram in LVH lambs was similarly 53% greater than in the sham-operated groups (7.51+0.6 versus 4.81±0.5 ml/min/g, p<0.03). However, the higher LV perfusion in LVH lambs was present only in the midmyocardium and subepimyocardium (p<0.03), whereas subendomyocardial flow during adenosine infusion was equivalent to that of nonbanded lambs (4.6±0.7 versus 4.4+0.6 ml/min/g, respectively).
In contrast to lambs with hypertrophy alone, lambs with both hypertrophy and protamine treatment had significantly lower maximal LV myocardial perfusion per gram (p<0.02) in all regions. As in LVH lambs, in LVH+P lambs the subendomyocardial perfusion during adenosine was significantly lower than subepimyocardial perfusion (59%,p<0.001). Thus, administration of protamine, an angiogenesis inhibitor, to young animals during development of pressure-overload LV hypertrophy reduced the coronary perfusion capacity. As is observed in adult animals with LV pressure-overload hypertrophy, the diminished perfusion predominated in the subendomyocardium.
Perfusion per gram in the RV was 53% greater than LV perfusion in the LVH+P lambs (p<0.02). genesis (e.g., alteration of coronary vascular reactivity or vessel drop out), RV vascular resistance (Figure 2) was measured in the same lambs. Minimum coronary vascular resistance in the RV was similar in all groups of lambs. Protamine-treated lambs had a slight, but not significant, elevation of RV minimum resistance per gram compared with SHAM and LVH, roughly proportional to the increase in RV mass associated with growth. In SHAM+P lambs, the minimum coronary vascular resistance per gram was similar in both ventricles, whereas in LVH+P lambs the resistance per gram was less in the RV than in the hypertrophied LV (p<0.055). The influence of protamine on vascular resistance was greater in the ventricle undergoing the largest increase in mass in response to aortic banding and growth. This is inconsistent with a generalized effect of protamine on vascular resistance independent of angiogenesis.
LV Wall and Capillary Morphometry
Samples for capillary density were judged inadequate for accurate cross-sectional capillary counts in two lambs (one LVH, one LVH+P) and were not included in the histological analysis. There were no significant differences in capillary density detected between the LV subendomyocardium (anterior papillary muscle) and the midmyocardium (free wall) within any of the groups (Table 3) .
LVH lambs had a significant increase in LV wall thickness compared with the BASE group (27±7%, p<O.OO1) ( Table 3 ) and yet inner and midwall capillary densities were similar to SHAM lambs due to an increase in LV cross-sectional capillary number concordant with the increase in LV mass (Figure 3 ). The number of capillaries across the LV wall was 27±6% greater in LVH lambs than in age-matched SHAM lambs (p<0.05) ( Figure 3A) . In LVH+P lambs, the number of capillaries across the LV wall ( Figure 3A Figure 3A) . In contrast to LVH+P lambs, chronic protamine administration did not demonstrably alter capillary density in either young SHAM+P or in adult sheep (n=4) compared with untreated age-matched sham controls (adult protamine-treated sheep, 105-110% of adult control sheep, p=NS). Capillary density in the less hypertrophied RV was not different in LVH+P compared with the other groups. Thus, the changes in capillary density qualitatively correlated with the changes in minimal coronary vascular resistance and were limited to the hypertrophied LV in LVH+P lambs. The diminished LV capillary density in LVH+P lambs is similar to findings of diminished subendomyocardial capillary density in adult animals with pressure-overload hypertrophy of similar duration.'2-17
Relation of Minimal Coronary Resistance and Capillary Density
Linear regression analysis was used to correlate changes in coronary capillary density and minimum vascular resistance observed in LVH and LVH+P lambs (Figure 4) . Capillary density was used as a general index of tissue vascularity. A direct physiological linkage between density and total coronary vascular resistance is limited since the majority of the coronary vascular resistance occurs proximal to the capillaries.4 '17-19 However, protamine inhibits growth of larger resistance vessels as well as capillaries.36 In hypertrophied adult myocardium, changes in the density of arteriolar resistance vessels are paralleled by similar changes in capillary density.'1 In this study, a significant inverse relation exists between LV minimum coronary vascular resistance and LV midwall capillary density in lambs with pressure-overload hypertrophy (r=0.66, p=0.004). This correlation between vascular density and vascular resistance observed with inhibition of angiogenesis provides support for the hypothesis linking coronary microvascular growth and coronary vascular resistance during development of pressure-overload hypertrophy.
Discussion
The development of LV pressure-overload hypertrophy in adults is accompanied by a decrease in microvascular densityl"17 and abnormal coronary vascular resistance,2,56,9"1'2 which may be due to inadequate growth of the coronary microvasculature.2,4-6,8-17 However, it has been difficult to separate the role of blunted coronary angiogenesis from other factors thought to influence microvascular density4J7"18 and minimum coronary vascular resistance4,6'12,'7,'9 in hypertensive vascular beds. These previous studies in mature animals of the role of angiogenesis in maintaining perfusion capacity in the hypertrophied LV have thus far been limited because of the lack of a system in which microvascular growth might be independently altered. In contrast to mature animals, young animals have ongoing coronary growth accompanying physiological myocardial growth. [13] [14] [15] [16] 25, 40 The coronary circulation of the young may therefore provide insight into the mechanisms in adults leading to diminished coronary flow reserve with LV hypertrophy. In this study, protamine sulfate, an angiogenesis inhibitor, was used to modulate coronary vascular growth in immature lambs during development of LV pressure-overload hypertrophy and to elucidate the impact of coronary vascular growth, or lack of growth, on the maintenance of coronary perfusion capacity in pressureoverload LV hypertrophy.
A principal finding of this study was that young lambs with LV pressure-overload hypertrophy have an increase in LV capillary number concordant with the increase in LV mass and maintenance of normal LV capillary density, coronary vascular resistance, and perfusion reserve. Therefore, at least in the young lamb with pressure-overload hypertrophy, the chronic increase in coronary systolic pressure did not appear to result in a change in coronary resistance in either the RV or LV. Similarly, LV myocardial compressive effects associated with the higher LV systolic pressure did not influence LV coronary resistance, although transmural flow distribution to the subendomyocardium may have been altered in the presence of adenosine-induced vasodilation. Administration of protamine sulfate during development of LV pressure-overload hypertrophy inhibited a concordant increase in LV capillaries and was associated with a diminished LV capillary density and maximal perfusion per gram. The LV minimum coronary resistance per gram, which may be an index of microvascular cross-sectional area,5 correlated inversely with LV capillary density and was elevated in hypertrophied lambs who received protamine. Thus, both physiological and morphometric assessments suggest that the cross-sectional area of the coronary vessels did not increase in proportion to the hypertrophy in protamine-treated lambs.
The magnitude of the changes in capillary density,ll-17 coronary perfusion reserve,2A4-7,9l1 and vascular resistance24561217 induced by LV pressure-overload hypertrophy in previous investigations in adult animals are similar to what we observed in young lambs with protamine inhibition of angiogenesis and LV pressureoverload hypertrophy of similar duration and severity. These findings support the concept that microvascular angiogenesis may be an important adaptive component of the myocardial hypertrophic response to pressure overload. In the young, coronary angiogenesis allows LV myocardial perfusion capacity to increase proportionally with LV mass. When coronary angiogenesis is insufficient for the increase in myocardial mass, as seen in adults with pressure-overload ventricular hypertrophy,1"-17'23'24 diminished myocardial perfusion capacity may result.4,6,7,9-12 Rakusan and Turek40 found that protamine inhibits coronary capillary angiogenesis accompanying physiological postnatal cardiac growth. In that investigation, the animals (rats) had much greater somatic and cardiac growth than the more mature lambs in this study. It is possible that protamine did not result in a measured decrease in capillary density in this study because the cardiac growth in the SHAM+P lambs was insufficient to induce a change in capillary density measurable with the histological and morphometric methods used. An effect of protamine on coronary capillary growth was only evident when the growth rate of the capillaries and LV mass was accelerated by pressure overload. We did observe a trend for increased minimal LV and RV resistance per gram in SHAM+P lambs. This may be a more sensitive index of vascular growth, since small changes in microvascular density and cross-sectional area may cause exponentially larger changes in vascular resistance. 18 A potential limitation of the use of protamine sulfate in the study of the hemodynamic impact of myocardial angiogenesis is the possibility of cardiovascular effects of protamine other than those due to inhibition of angiogenesis (e.g., alteration of coronary vascular reactivity, arterial thickening, generalized vascular toxic effects leading to vessel drop out, and inhibition of myocardial growth or function). Protamine may influence systems (e.g., DNA histone, vascular wall heparin-smooth muscle interactions,47 nonvascular receptors for bFGF, platelet-derived growth factor,48 and insulin49) that potentially could alter coronary vessels or affect myocardial growth and lead to confounding effects. However, in a previous study,50 no acute systemic hemodynamic effects were observed in sheep after protamine administration. Chronic high dose protamine administration to humans for treatment of malignancy resulted in no reported cardiovascular side effects. 46 In previous studies,36,37 protamine inhibition of capillary proliferation appeared to be specific and reversible. Protamine did not inhibit proliferation of a number of nonendothelial cell lines.36 Protamine treatment of young, rapidly growing mice40 resulted in only a slight reduction in body and heart weight and no apparent cardiac pathology apart from inhibition of angiogenesis.
In the present study, physiological cardiac growth and the LV hypertrophic response to pressure overload did not appear to be impaired in lambs given protamine. The specificity of protamine actions on coronary growth, blood flow, and vascular reactivity was examined using coronary flow to the RV as an internal control. Unlike the LV, RV capillarity and minimal coronary vascular resistance were not affected by protamine. The unchanged RV minimum resistance indicates that protamine does not cause a change in hypertensive coronary resistance vessels independent of ventricular hypertrophy. The specificity of protamine action was further investigated using age-matched growing lambs that received protamine but did not have pressureoverload hypertrophy and adult sheep that received protamine but had neither hypertrophy nor physiological growth. Unlike lambs with hypertrophy, protamine administration to sham-operated lambs and to nongrowing adult sheep had no significant effect on coronary perfusion or capillary density. The relative specificity of the effect of protamine suggests that the inhibitory effect of protamine on coronary perfusion was specific to hypertrophying ventricles with growing vasculature. The histological data demonstrated that changes in vascular resistance were paralleled by a decrease in capillary density, supporting the contention that the changes in coronary vascular resistance associated with protamine were a result of impaired neovascularization.
Protamine inhibits the growth of larger vessels as well as capillaries. 36 35 and inhibition of coronary angiogenesis by protamine suggests that cardiac heparin-binding growth factors may play a role in microvascular growth accompanying pressure-overload hypertrophy in the young. The role of heparin and heparin-binding growth factors in coronary neovascularization in the young and in the adult deserves further study. The ability to downregulate coronary angiogenesis with protamine and to upregulate it with thyroxine4 demonstrates that the process can be pharmacologically modulated, suggesting a potential for the use of angiogenesis promoters in adult hypertrophic and ischemic heart disease.
In conclusion, the immature lamb increases LV capillary number and maintains minimum coronary vascular resistance and maximum coronary perfusion during development of pressure-overload hypertrophy. The angiogenesis inhibitor protamine impedes coronary microvascular growth accompanying LV hypertrophy in the young lamb, resulting in diminished capillary density and maximum myocardial perfusion and elevated LV minimum coronary vascular resistance. These findings provide evidence that coronary angiogenesis is important in maintaining perfusion reserve during LV pressureoverload hypertrophy in the immature LV. Inhibition of myocardial angiogenesis with protamine sulfate suggests that heparin and heparin-binding growth factors may promote coronary neovascularization with pressure-overload hypertrophy in the young. Angiogenesis inhibitors may provide a means of clarifying the relation of coronary vascular growth and perfusion, as well as the impact of limited microvascular growth, on alterations in myocardial function reserve and electrophysiological function in pressure-overload hypertrophy.
